SCHEMBL10031320

SCHEMBL10031320

CCOC(=O)OC[C@H]1O[C@@H](OC)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC5A1 P13866 4/20 0.52
▸ SLC5A2 P31639 4/20 0.52
▸ TLR4 O00206 1/20 0.43
▸ PRKD3 O94806 1/20 0.43
▸ PRKCG P05129 1/20 0.43
▸ PRKCB P05771 1/20 0.43
▸ PRKCA P17252 1/20 0.43
▸ PRKCH P24723 1/20 0.43
▸ PRKCI P41743 1/20 0.43
▸ PRKCE Q02156 1/20 0.43
▸ PRKCQ Q04759 1/20 0.43
▸ PRKCZ Q05513 1/20 0.43
▸ PRKCD Q05655 1/20 0.43
▸ PRKD1 Q15139 1/20 0.43
▸ G6PD P11413 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP2C19 P33261 1/20 0.39
▸ SOAT1 P35610 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17866100 0.82 ALDH1A1 (0.45) SLC5A1SLC5A2TLR4PRKD3PRKCG
SCHEMBL28205738 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL7150078 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL17253655 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL12038195 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL13752014 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL14175697 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL7146273 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL2320839 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL13929473 0.82 PRKD3 (0.46) TLR4PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053330-A1 Chemical Process GLAXOSMITHKLINE LLC 2012-03-01 — — US disclosed
US-20120053330-A1 Chemical Process GLAXOSMITHKLINE LLC 2012-03-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053330-A1 Chemical Process SLC5A2, SLC5A1, UGGT1 SLC5A1 2/4885SLC5A2 1/4885TLR4 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback